4-[2-(2-ethoxy-1,1-difluoro-2-oxoethyl)-1-(4-fluorophenyl)-4-phenylmethoxyindol-3-yl]benzoic acid
C32H24F3NO5 — CID 156878382
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-(2-ethoxy-1,1-difluoro-2-oxoethyl)-1-(4-fluorophenyl)-4-phenylmethoxyindol-3-yl]benzoic acid
4-[2-(2-ethoxy-1,1-difluoro-2-oxoethyl)-1-(4-fluorophenyl)-4-phenylmethoxyindol-3-yl]benzoic acid (PubChem CID 156878382) has the molecular formula C32H24F3NO5 and a molecular weight of 559.54 g/mol. Its IUPAC name is 4-[2-(2-ethoxy-1,1-difluoro-2-oxoethyl)-1-(4-fluorophenyl)-4-phenylmethoxyindol-3-yl]benzoic acid.
Molecular Properties
| Compound Name | 4-[2-(2-ethoxy-1,1-difluoro-2-oxoethyl)-1-(4-fluorophenyl)-4-phenylmethoxyindol-3-yl]benzoic acid |
|---|---|
| PubChem CID | 156878382 |
| Molecular Formula | C32H24F3NO5 |
| Molecular Weight | 559.54 g/mol |
| Exact Mass | 559.16 |
| IUPAC Name | 4-[2-(2-ethoxy-1,1-difluoro-2-oxoethyl)-1-(4-fluorophenyl)-4-phenylmethoxyindol-3-yl]benzoic acid |
| SMILES | CCOC(=O)C(F)(F)c1c(-c2ccc(C(=O)O)cc2)c2c(OCc3ccccc3)cccc2n1-c1ccc(F)cc1 |
| InChI | InChI=1S/C32H24F3NO5/c1-2-40-31(39)32(34,35)29-27(21-11-13-22(14-12-21)30(37)38)28-25(36(29)24-17-15-23(33)16-18-24)9-6-10-26(28)41-19-20-7-4-3-5-8-20/h3-18H,2,19H2,1H3,(H,37,38) |
| InChIKey | WXEVMIANMQQZLR-UHFFFAOYSA-N |
| XLogP | 7.37 |
| TPSA | 77.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 559.54 |
| LogP ≤ 5 | 7.37 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156878382 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.